BE903497A - Composition pharmaceutique - Google Patents
Composition pharmaceutiqueInfo
- Publication number
- BE903497A BE903497A BE0/215762A BE215762A BE903497A BE 903497 A BE903497 A BE 903497A BE 0/215762 A BE0/215762 A BE 0/215762A BE 215762 A BE215762 A BE 215762A BE 903497 A BE903497 A BE 903497A
- Authority
- BE
- Belgium
- Prior art keywords
- pharmaceutical composition
- reduce
- cadmium
- isomer
- inhibit
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- MMWCIQZXVOZEGG-HOZKJCLWSA-N [(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate Chemical compound O[C@H]1[C@@H](O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](O)[C@H]1OP(O)(O)=O MMWCIQZXVOZEGG-HOZKJCLWSA-N 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract 1
- 229910052782 aluminium Inorganic materials 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 229910052793 cadmium Inorganic materials 0.000 abstract 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/30—Organic phosphorus compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B7/00—Preservation or chemical ripening of fruit or vegetables
- A23B7/14—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10
- A23B7/153—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10 in the form of liquids or solids
- A23B7/154—Organic compounds; Microorganisms; Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/05—Organic compounds containing phosphorus as heteroatom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3553—Organic compounds containing phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
Abstract
Composition pharmaceutique contenant en tant qu'ingrédient pharmaceutiquement actif au moins un isomère de l'inositol-triphosphate (IP3), dans une quantité suffisante pour réduire les effets négatifs du cadmium ou de l'aluminium dans le corps ou pour inhiber ou réduire la formation de radicaux libres dans le corps.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8405295A SE465951B (sv) | 1984-10-23 | 1984-10-23 | Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav |
Publications (1)
Publication Number | Publication Date |
---|---|
BE903497A true BE903497A (fr) | 1986-02-17 |
Family
ID=20357457
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/215763A BE903498A (fr) | 1984-10-23 | 1985-10-22 | Inositol-triphosphate |
BE0/215762A BE903497A (fr) | 1984-10-23 | 1985-10-22 | Composition pharmaceutique |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/215763A BE903498A (fr) | 1984-10-23 | 1985-10-22 | Inositol-triphosphate |
Country Status (19)
Country | Link |
---|---|
US (7) | US4734283A (fr) |
EP (3) | EP0179440B1 (fr) |
JP (4) | JPS61171491A (fr) |
AT (3) | ATE41853T1 (fr) |
AU (3) | AU596080B2 (fr) |
BE (2) | BE903498A (fr) |
CH (2) | CH666812A5 (fr) |
DE (6) | DE3577851D1 (fr) |
DK (2) | DK172852B1 (fr) |
FI (3) | FI85490C (fr) |
FR (2) | FR2571967B1 (fr) |
GB (3) | GB2169602B (fr) |
HU (1) | HU196077B (fr) |
IL (1) | IL76777A (fr) |
IT (2) | IT1190402B (fr) |
NO (3) | NO169010C (fr) |
NZ (1) | NZ213855A (fr) |
SE (6) | SE465951B (fr) |
ZA (4) | ZA858105B (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0252227B1 (fr) * | 1986-04-16 | 1994-04-13 | Perstorp Ab | Utilisation de l'inositol-triphosphate pour le traitement de l'intoxication par des métaux |
Families Citing this family (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5095035A (en) * | 1981-07-31 | 1992-03-10 | Eby Iii George A | Flavor stable zinc acetate compositions for oral absorption |
US5407924A (en) * | 1984-10-23 | 1995-04-18 | Perstorp Ab | Method of treating pain using inositol triphosphate |
US4735902A (en) * | 1984-10-23 | 1988-04-05 | Matti Siren | Stabilized composition containing inositoltriphosphate |
US5330979A (en) * | 1984-10-23 | 1994-07-19 | Perstorp Ab | Method of treating renal disorders with inositoltriphosphate |
US5128332A (en) * | 1984-10-23 | 1992-07-07 | Perstorp Ab | Method of treating cardiovascular diseases using inositoltrisphosphate |
SE465951B (sv) * | 1984-10-23 | 1991-11-25 | Perstorp Ab | Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav |
JPS63198642A (ja) * | 1986-03-11 | 1988-08-17 | Mitsui Toatsu Chem Inc | ミオイノシトール誘導体の製造方法 |
US4952717A (en) * | 1986-03-11 | 1990-08-28 | Mitsui Toatsu Chemicals, Incorporated | Myoinositol derivatives and preparation process thereof |
US5057507A (en) * | 1986-04-16 | 1991-10-15 | Perstorp Ab | Method of alleviating bone damage with inositoltriphosphate |
WO1988003365A1 (fr) * | 1986-11-05 | 1988-05-19 | George Weston Foods Limited | Nouveaux agents d'amelioration pour aliments a base de farine et autres aliments cuits au four et montes a la levure |
SE8605063D0 (sv) * | 1986-11-26 | 1986-11-26 | Matti Siren | Derivatives of cyclohexane |
US5274161A (en) * | 1986-11-26 | 1993-12-28 | Perstorp Ab | Derivatives of cyclohexane |
GB8705811D0 (en) * | 1987-03-11 | 1987-04-15 | Research Corp Ltd | Inositol derivatives |
JP2597618B2 (ja) * | 1987-12-28 | 1997-04-09 | 三井東圧化学 株式会社 | 光学分割方法 |
JPH01287035A (ja) * | 1988-05-13 | 1989-11-17 | Sanwa Kagaku Kenkyusho Co Ltd | 薬物並びにアルコール性中毒の予防剤とその治療剤 |
JPH01294631A (ja) * | 1988-05-19 | 1989-11-28 | Sanwa Kagaku Kenkyusho Co Ltd | 糖尿性疾患治療予防剤及び飲食、し好物 |
SE464059C (sv) * | 1988-09-15 | 1996-12-04 | Perstorp Ab | Användning av inositoltrifosfat för framställning av läkemedel |
US5316770A (en) * | 1989-02-16 | 1994-05-31 | University Of Georgia Research Foundation, Inc. | Vitamin D derivative feed compositions and methods of use |
US5366736A (en) * | 1989-02-16 | 1994-11-22 | University Of Georgia Research Foundation, Inc. | Vitamin D derivative feed compositions and methods of use |
DE69033560T2 (de) * | 1989-03-08 | 2001-03-01 | Univ Virginia | Arzneimittel für insulinresistente diabetiker |
US5428066A (en) * | 1989-03-08 | 1995-06-27 | Larner; Joseph | Method of reducing elevated blood sugar in humans |
US5750348A (en) * | 1989-03-08 | 1998-05-12 | The University Of Virginia Patents Foundation | Method for detecting insulin resistance |
US5427956A (en) * | 1989-03-08 | 1995-06-27 | The University Of Virginia Patent Foundation | Quantitative analysis for diabetic condition predictor |
SE8902766D0 (sv) * | 1989-08-17 | 1989-08-17 | Siren Matti | Saett att oeka den farmaceutiska effekten av inositolfosfat samt en beredning med foerbaettrad farmaceutisk effekt |
SE8904355D0 (sv) * | 1989-12-21 | 1989-12-21 | Perstorp Ab | Medicament |
US7033627B2 (en) | 1990-03-23 | 2006-04-25 | Syngenta Mogen B.V. | Production of enzymes in seeds and their use |
KR100225087B1 (ko) * | 1990-03-23 | 1999-10-15 | 한스 발터라벤 | 피타아제의 식물내 발현 |
US5543576A (en) * | 1990-03-23 | 1996-08-06 | Mogen International | Production of enzymes in seeds and their use |
US5593963A (en) * | 1990-09-21 | 1997-01-14 | Mogen International | Expression of phytase in plants |
SE9002278L (sv) * | 1990-06-28 | 1991-12-29 | Perstorp Ab | Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel |
WO1992004037A1 (fr) * | 1990-08-29 | 1992-03-19 | Sterling Chaykin | Procede et produit servant a eliminer les effets secondaires indesirables dus a l'ingestion de legumes tels que l'oignon ou l'ail |
US6007809A (en) * | 1990-08-29 | 1999-12-28 | Chaykin; Sterling | Method and product for eliminating undesirable side effects of eating vegetables such as onion or garlic |
US5514398A (en) * | 1990-11-05 | 1996-05-07 | Amano Pharmaceutical Co., Ltd. | Food additive and use thereof |
SE9102068L (sv) * | 1991-07-03 | 1993-01-04 | Perstorp Ab | Derivat av inositol, kompositioner innehaallande dessa samt anvaendning daerav |
SE9200547L (sv) * | 1992-02-25 | 1993-06-14 | Perstorp Ab | En farmaceutisk komposition med foerbaettrad biotillgaenglighet avseende inositolfosfat |
US5292537A (en) * | 1992-11-12 | 1994-03-08 | Bran Tec, Inc. | Method for stabilizing rice bran and rice bran products |
JP2696057B2 (ja) * | 1993-05-11 | 1998-01-14 | ニチモウ株式会社 | 穀類を原料とした生成物の製造方法 |
WO1995005830A1 (fr) * | 1993-08-20 | 1995-03-02 | The Regents Of The University Of California | Agents anti-inflammatoires polyanioniques |
SE502989C2 (sv) * | 1993-11-22 | 1996-03-04 | Perstorp Ab | Användning av en inositoltrisfosfatester för beredning av läkemedel |
SE503122C2 (sv) * | 1993-11-22 | 1996-03-25 | Perstorp Ab | Användning av en inositoltrisfosfatester för behandling av inflammatoriska tillstånd |
US5466465A (en) * | 1993-12-30 | 1995-11-14 | Harrogate Holdings, Limited | Transdermal drug delivery system |
SE502574C2 (sv) * | 1994-01-25 | 1995-11-13 | Perstorp Ab | En farmaceutisk komposition med förbättrad biotillgänglighet hos inositolfosfat |
US6451572B1 (en) | 1998-06-25 | 2002-09-17 | Cornell Research Foundation, Inc. | Overexpression of phytase genes in yeast systems |
BR0009516B1 (pt) | 1999-03-31 | 2013-09-10 | vetor recombinante e célula hospedeira microbiana. | |
US6841370B1 (en) | 1999-11-18 | 2005-01-11 | Cornell Research Foundation, Inc. | Site-directed mutagenesis of Escherichia coli phytase |
AU2733101A (en) | 1999-12-30 | 2001-07-16 | Wake Forest University | Cadmium is a risk factor for human pancreatic cancer |
US20020193379A1 (en) * | 2001-06-05 | 2002-12-19 | Insmed Incorporated | Compositions and methods for decreasing the risk of or preventing neural tube disorders in mammals |
FR2828206B1 (fr) * | 2001-08-03 | 2004-09-24 | Centre Nat Rech Scient | Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire |
PT2335501T (pt) * | 2001-10-31 | 2016-10-28 | Huvepharma Ad | Alimento animal contendo fitase e método |
US20050108780A1 (en) * | 2002-01-24 | 2005-05-19 | Erasmus University | Intracellular antibodies for a retrovirus protein |
AU2003231157C1 (en) * | 2002-04-29 | 2009-02-26 | Normoxys, Inc. | Inositol pyrophosphates, and methods of use thereof |
ATE492631T1 (de) * | 2002-09-13 | 2011-01-15 | Cornell Res Foundation Inc | Verwendung von mutationen zur verbesserung von aspergillus-phytasen |
CA2413240A1 (fr) * | 2002-11-29 | 2004-05-29 | Mcn Bioproducts Inc. | Purification de l'inositol extrait de matieres vegetales |
US20050123644A1 (en) * | 2003-01-24 | 2005-06-09 | Cargill, Incorporated | Phosphate-containing fertilizer derived from steepwater |
US7521481B2 (en) * | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
US20050048165A1 (en) * | 2003-03-31 | 2005-03-03 | Sadanandan Bindu | Process for the preparation of Chapathi dough with reduced phytic acid level |
US20070135389A1 (en) * | 2004-07-06 | 2007-06-14 | Claude Nicolau | Tumor eradication by inositol-tripyrophosphate |
US20060106000A1 (en) * | 2004-07-06 | 2006-05-18 | Claude Nicolau | Use of inositol-tripyrophosphate in treating tumors and diseases |
US20060258626A1 (en) * | 2004-07-06 | 2006-11-16 | Claude Nicolau | Use of inositol-tripyrophosphate in treating tumors and diseases |
US7745423B2 (en) * | 2004-07-06 | 2010-06-29 | NormOxys, Inc | Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin |
CA2601641A1 (fr) * | 2005-03-18 | 2006-09-28 | Oxyplus, Inc. | Sel de calcium de myo-inositol 1,6:2,3:4,5 tripyrophosphate utile comme effecteur allosterique de l'hemoglobine |
US7919297B2 (en) | 2006-02-21 | 2011-04-05 | Cornell Research Foundation, Inc. | Mutants of Aspergillus niger PhyA phytase and Aspergillus fumigatus phytase |
US20070212449A1 (en) * | 2006-03-02 | 2007-09-13 | Shamsuddin Abulkalam M | Reduction of the titratable acidity and the prevention of tooth and other bone degeneration |
EP2069486A2 (fr) * | 2006-08-03 | 2009-06-17 | Cornell Research Foundation, Inc. | Phytases presentant une stabilite thermique amelioree |
US20090214474A1 (en) * | 2006-11-01 | 2009-08-27 | Barbara Brooke Jennings | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
US20080103116A1 (en) * | 2006-11-01 | 2008-05-01 | Jennings-Spring Barbara L | Method of treatment and compositions of D-chiro inositol and phosphates thereof |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
EP2152085A4 (fr) * | 2007-05-01 | 2012-05-23 | Normoxys Inc | Complémentation ou remplacement d'érythropoïétine |
US8192734B2 (en) | 2007-07-09 | 2012-06-05 | Cornell University | Compositions and methods for bone strengthening |
WO2009038533A1 (fr) * | 2007-09-17 | 2009-03-26 | Bioneris Ab | Procédé et moyens pour le traitement de la cachexie |
KR20170129281A (ko) * | 2011-07-01 | 2017-11-24 | 가부시키가이샤 시세이도 | 혈소판 유래 성장 인자-bb 생성 항진제, 및 그것을 포함하는 간엽계 줄기세포 생성 촉진제, 줄기세포 안정화제, 및 진피 재생화제 |
FR3017134B1 (fr) * | 2014-02-06 | 2018-04-20 | Lesaffre Et Compagnie | Levure biologique, procede d'obtention et utilisations |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2723938A (en) * | 1952-12-05 | 1955-11-15 | Bristol Lab Inc | Aqueous penicillin suspensions comprising inositol phosphoric acids and their salts |
US3591665A (en) * | 1967-09-08 | 1971-07-06 | Mitsui Toatsu Chemicals | Process for producing phytic acid |
FI51469C (fi) * | 1968-01-10 | 1977-01-10 | Morinaga Milk Industry Co Ltd | Menetelmä radioaktiivisen strontium 90 saasteen poistamiseksi nestemäi sistä elintarvikkeista tai vedestä. |
JPS50111246A (fr) * | 1974-02-14 | 1975-09-01 | ||
US4154824A (en) * | 1976-07-20 | 1979-05-15 | Interx Research Corporation | Nonbitter tasting potassium product for oral administration to warm-blooded animals and method for preparing same |
JPS53124636A (en) * | 1977-04-04 | 1978-10-31 | Kisaku Mori | Method of increasing meranine contained in animal and plant |
DE2740053A1 (de) * | 1977-09-06 | 1979-05-03 | Klaus Prof Dr Med Gersonde | Verwendung von allosterischen effektoren mit hilfe von lipidvesikeln ueber eine irreversible inkorporierung zwecks verbesserter o tief 2 -entladung des haemoglobins in erythrozyten |
JPS5486666A (en) * | 1977-12-22 | 1979-07-10 | Ajinomoto Kk | Cola beverage |
JPS5798292A (en) * | 1980-12-09 | 1982-06-18 | Jiyaade:Kk | Powdery phytic acid and its preparation |
JPS58198254A (ja) * | 1982-05-14 | 1983-11-18 | Kyowa Hakko Kogyo Co Ltd | 加工食品の品質改良法 |
SE450325B (sv) * | 1983-02-23 | 1987-06-22 | Tricum Ab | Kostfiberprodukt baserad pa skaldelar fran froet hos ceralier |
US4735902A (en) * | 1984-10-23 | 1988-04-05 | Matti Siren | Stabilized composition containing inositoltriphosphate |
SE465951B (sv) * | 1984-10-23 | 1991-11-25 | Perstorp Ab | Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav |
AU2001248278A1 (en) | 2000-04-13 | 2001-10-30 | Novozymes A/S | Extracellular expression of pectate lyase using bacillus or escherichia coli |
-
1984
- 1984-10-23 SE SE8405295A patent/SE465951B/sv not_active IP Right Cessation
-
1985
- 1985-06-26 SE SE8503165A patent/SE8503165L/xx not_active Application Discontinuation
- 1985-06-26 SE SE8503164A patent/SE8503164L/xx not_active Application Discontinuation
- 1985-10-16 NZ NZ213855A patent/NZ213855A/xx unknown
- 1985-10-18 US US06/788,823 patent/US4734283A/en not_active Expired - Fee Related
- 1985-10-18 US US06/788,801 patent/US4735936A/en not_active Expired - Lifetime
- 1985-10-18 US US06/788,829 patent/US4777134A/en not_active Expired - Lifetime
- 1985-10-22 BE BE0/215763A patent/BE903498A/fr not_active IP Right Cessation
- 1985-10-22 GB GB08526079A patent/GB2169602B/en not_active Expired
- 1985-10-22 SE SE8504969A patent/SE8504969L/xx not_active Application Discontinuation
- 1985-10-22 BE BE0/215762A patent/BE903497A/fr not_active IP Right Cessation
- 1985-10-22 NO NO854212A patent/NO169010C/no unknown
- 1985-10-22 AU AU48932/85A patent/AU596080B2/en not_active Ceased
- 1985-10-22 AT AT85113383T patent/ATE41853T1/de not_active IP Right Cessation
- 1985-10-22 NO NO854211A patent/NO854211L/no unknown
- 1985-10-22 JP JP60234666A patent/JPS61171491A/ja active Granted
- 1985-10-22 DE DE8585113382T patent/DE3577851D1/de not_active Expired - Lifetime
- 1985-10-22 ZA ZA858105A patent/ZA858105B/xx unknown
- 1985-10-22 DK DK198504832A patent/DK172852B1/da not_active IP Right Cessation
- 1985-10-22 IT IT22573/85A patent/IT1190402B/it active
- 1985-10-22 ZA ZA858108A patent/ZA858108B/xx unknown
- 1985-10-22 SE SE8504968A patent/SE465164B/sv not_active IP Right Cessation
- 1985-10-22 ZA ZA858107A patent/ZA858107B/xx unknown
- 1985-10-22 EP EP85113382A patent/EP0179440B1/fr not_active Expired - Lifetime
- 1985-10-22 FI FI854126A patent/FI85490C/fi not_active IP Right Cessation
- 1985-10-22 JP JP60234667A patent/JPS61181347A/ja active Granted
- 1985-10-22 DE DE19853537550 patent/DE3537550A1/de not_active Withdrawn
- 1985-10-22 CH CH4536/85A patent/CH666812A5/fr not_active IP Right Cessation
- 1985-10-22 DE DE19853537542 patent/DE3537542A1/de not_active Withdrawn
- 1985-10-22 JP JP60234668A patent/JPS61171789A/ja active Granted
- 1985-10-22 AT AT85113381T patent/ATE37788T1/de not_active IP Right Cessation
- 1985-10-22 NO NO854213A patent/NO168227C/no unknown
- 1985-10-22 EP EP85113383A patent/EP0179441B1/fr not_active Expired
- 1985-10-22 AU AU48931/85A patent/AU582594B2/en not_active Ceased
- 1985-10-22 FR FR8515675A patent/FR2571967B1/fr not_active Expired
- 1985-10-22 DE DE19853537569 patent/DE3537569A1/de not_active Withdrawn
- 1985-10-22 DK DK198504833A patent/DK172857B1/da not_active IP Right Cessation
- 1985-10-22 FI FI854127A patent/FI82474C/fi not_active IP Right Cessation
- 1985-10-22 HU HU854074A patent/HU196077B/hu not_active IP Right Cessation
- 1985-10-22 AT AT85113382T patent/ATE53038T1/de not_active IP Right Cessation
- 1985-10-22 EP EP85113381A patent/EP0179439B1/fr not_active Expired
- 1985-10-22 JP JP60234665A patent/JPS61171422A/ja active Granted
- 1985-10-22 SE SE8504967A patent/SE8504967L/xx not_active Application Discontinuation
- 1985-10-22 AU AU48930/85A patent/AU589378B2/en not_active Ceased
- 1985-10-22 DE DE8585113383T patent/DE3569188D1/de not_active Expired
- 1985-10-22 IT IT22574/85A patent/IT1190403B/it active
- 1985-10-22 FR FR8515676A patent/FR2573080B1/fr not_active Expired
- 1985-10-22 FI FI854128A patent/FI88855C/fi not_active IP Right Cessation
- 1985-10-22 GB GB08526078A patent/GB2167298B/en not_active Expired
- 1985-10-22 ZA ZA858106A patent/ZA858106B/xx unknown
- 1985-10-22 GB GB8526080A patent/GB2167283B/en not_active Expired
- 1985-10-22 IL IL76777A patent/IL76777A/xx not_active IP Right Cessation
- 1985-10-22 CH CH4537/85A patent/CH668597A5/fr not_active IP Right Cessation
- 1985-10-22 DE DE8585113381T patent/DE3565464D1/de not_active Expired
-
1987
- 1987-02-17 US US07/015,679 patent/US4797390A/en not_active Expired - Lifetime
- 1987-02-17 US US07/015,699 patent/US4851560A/en not_active Expired - Fee Related
- 1987-02-17 US US07/015,676 patent/US4794014A/en not_active Expired - Lifetime
-
1988
- 1988-07-01 US US07/214,500 patent/US5003098A/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0252227B1 (fr) * | 1986-04-16 | 1994-04-13 | Perstorp Ab | Utilisation de l'inositol-triphosphate pour le traitement de l'intoxication par des métaux |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE903497A (fr) | Composition pharmaceutique | |
ATE153855T1 (de) | Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten | |
ATE56356T1 (de) | Brausepaare, h2-antagonisten von histamin enthaltende brausemischungen und verfahren zu ihrer herstellung. | |
EP0041772A3 (en) | Fat emulsion containing a steroid | |
FR2378523A1 (fr) | Medicament pour le traitement de l'acne | |
FR2415112A1 (fr) | Nouveaux derives spirothienohydantoines et composition pharmaceutique les contenant | |
FR2440737A1 (fr) | Emulsion de graisse pour injection intraveineuse | |
FR2403333A1 (fr) | Analogues de la prostaglandine e1 et compositions pharmaceutiques les contenant | |
FR2430198A1 (fr) | Emulsion insecticide et acaricide de type huile dans l'eau | |
FR2398067A1 (fr) | Nouvelles 4-pyrones substituees en positions 2, 3 et 6 et medicament les contenant | |
BE904740A (fr) | Utilisation (s)-(+)hydroprene pour combattre les blattes. | |
FR2422654A1 (fr) | Analogues de prostacycline et medicament les contenant | |
FR2399841A1 (fr) | Combinaison medicamenteuse antithrombotique et procede pour sa preparation | |
FR2419935A1 (fr) | Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant | |
FR2372190A1 (fr) | Composes organiques du silicium comprenant au moins un radical alcenyloxy et compositions thermodurcissables les contenant | |
FR2435945A1 (fr) | Perfectionnements a des compositions contenant de l'etomidate | |
BE902055A (fr) | Preparations pharmaceutiques. | |
FR2422403A1 (fr) | Compositions therapeutiques diuretiques a effet rapide, a base d'acide 4-chloro-n-furfuryl-5-sulfamoylanthranilique et de composes de pteridine | |
FR2359122A1 (fr) | Nouvelles amidines aromatiques et composition antivirale les contenant | |
BE900186A (fr) | Compositions fongicides synergiques. | |
BE899531A (fr) | Derives sulfures de l'hydantoine et compositions pharmaceutiques les contenant. | |
FR2417983A1 (fr) | Composition pharmaceutique anti-ulcere contenant, en tant qu'ingredient actif, de l'hexasulfate d'inositol ou un sel de celui-ci |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: SIREN MATTI Effective date: 19891031 |